Bowel cancer cells can “shapeshift” to resemble skin or muscle cells to enable them to spread aggressively, according to scientists who have hailed it as a major breakthrough they hope can help treat ...

HEAD and neck cancer (HNC) ranks among the most common cancers worldwide, with higher incidence in developing countries. Risk ...

Lung cancer is a dangerous disease that ranks first in cancer mortality in Korea, and there are few initial symptoms, making ...

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / June 9, 2025 / Jaguar Health, Inc. ( NASDAQ:JAGX) today issued a reminder that Lisa Conte, the company's founder, president and CEO, will participate in a ...

Cancer cannot be understood as a single, uniform disease. The more we delve into studying each type of tumor, the more we ...

An expert discusses how treatment decisions in metastatic castration-resistant prostate cancer (mCRPC) increasingly depend on prior androgen receptor pathway inhibitor (ARPI) exposure, highlighting ...

Productive and collaborative discussion on proposed pathway by the company to bring crofelemer to approval for cancer therapy ...

ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...

Nivolumab plus ipilimumab did not improve OS vs chemotherapy in patients with previously untreated, unresectable/metastatic urothelial carcinoma.

A team of researchers at the University of Minnesota recently completed a human trial for a novel gene-editing treatment, ...

Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung ...

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.